查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球抗組胺藥市場 (2022-2028)
市場調查報告書
商品編碼
1215696

全球抗組胺藥市場 (2022-2028)

Antihistamine Drugs Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3個工作天內

價格

在預測期內，全球抗組胺藥市場規模預計將以 8.7% 的複合年增長率顯著增長。 全球抗組胺藥市場主要受醫療成本上升和醫療行業對新技術投資的高需求等因素推動。 此外，增加治療各種過敏性疾病的診斷方法和對治療可用性的認識不斷提高也是推動市場增長的重要因素。

本報告考察了全球抗組胺藥市場，並提供了市場概況、競爭格局、細分市場、區域分析和公司概況。

內容

第 1 章報告概述

第 2 章市場概述和注意事項

  • 調查範圍
  • 分析師見解和當前市場趨勢

第三章競爭格局

  • 主要公司分析
    • 概覽
    • 財務分析
    • SWOT 分析
    • 近期趨勢
  • 關鍵策略分析

第 4 章市場決定因素

  • 司機
  • 約束因素
  • 機會

第 5 章市場細分

  • 全球抗組胺藥市場，按類型
    • H-1 受體拮抗劑
    • H-2 受體拮抗劑
  • 全球抗組胺藥市場：按應用分類
    • 流感/感冒
    • 過敏症
    • 皮炎
    • 蕁麻疹
    • 其他
  • 全球抗組胺藥市場：按最終用戶分類
    • 家庭護理
    • 醫院和診所
    • 其他 (ACS)

第六章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他地區
    • 拉丁美洲
    • 中東和非洲

第七章公司簡介

  • Akorn, Inc.
  • Almirall S.A.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH.
  • Bristol-Myers Squibb Co.
  • Cadila Pharmaceuticals, Ltd.
  • F. Hoffmann-La Roche, Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Ltd.
  • Meda Consumer Healthcare, Inc.
  • Merck & Co.
  • Mylan N.V.
  • Novartis International AG
  • Pfizer, Inc.
Product Code: OMR2026752

Title:Global Antihistamine Drugs Market Size, Share, and Trends Analysis Report, by Drug Type (H-1 Receptor Antagonist and H-2 Receptor Antagonists), by Application (Flu and Cold, Allergy, Dermatitis, Urticaria, and Others), by End-User (Homecare, Hospitals and Clinics, and Others), Forecast Period (2022-2028).

The global antihistamine drugs market is anticipated to grow at a substantial CAGR of 8.7% during the forecast period. The global antihistamine drugs market is primarily driven by the factors such as rising healthcare expenditure and the high demand for new technological investment in the healthcare sector. Moreover, increasing diagnostic methods to treat various allergic diseases and the growing rate of awareness about the availability of treatments are the other prominent factors that have broken the market growth. For instance, FARE, one of the largest private funders of food allergy research, promotes the development of new therapies and offers hope for effective treatments. Similarly, in March 2022, around $26.9 million investment into allergy prevention and management was announced by the Centre for Food & Allergy Research (CFAR) under the 2022 federal government budget. Such initiatives are projected to bring new growth opportunities to the market.

The global antihistamine drugs market is segmented based on drug type, application, and end-user. Based on drug type, the market is sub-segmented into H-1 receptor antagonists (including, brompheniramine, diphenhydramine, cetirizine, desloratadine, loratadine, fexofenadine, and others) and H-2 receptor antagonists (including, cimetidine, famotidine, nizatidine, ranitidine, and other). Based on application, it is further classified into flu and cold, allergy, dermatitis, urticaria, and others. Among these, the allergy segment is projected to show promising growth during the forecasted period. The segment growth is driven by the factors such as the rising prevalence of allergic rhinitis which has further surged the other problems such as asthma, sinus, or ear conditions due to which the demand for the antihistamine drugs is considerably high. Moreover, allergic rhinitis therapies under development are focused on novel approaches to treat/improve diseased conditions. This can lead to the generation of new growth opportunities in the market. Similarly, based on end-user, the global antihistamine drugs market is categorized into home care, hospitals and clinics, and others.

Geographically, the antihistamine drugs are segmented into North America, Europe, Asia-Pacific, and the Rest of the World. A large amount of R&D expenditure for the development of allergy treatment, the rising prevalence of food allergies, and huge healthcare investments are expected to drive the antihistamine drugs market growth in the North American region. Europe is anticipated to be the second-fastest-growing market followed by the Asia-Pacific market. The growing awareness about perennial allergic rhinitis and the availability of good treatment options in the market can aid in the market growth in the respective regions.

The major market players in the global antihistamine drugs include Johnson & Johnson Services Ltd., Sanofi SA, Bayer AG, Novartis International AG, AstraZeneca PLC, GlaxoSmithKline PLC, Pfizer Inc., and Merck & Co., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global antihistamine drugs market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Antihistamine Drugs Research and Analysis by Drug Type
  • Global Antihistamine Drugs Research and Analysis by Application
  • Global Antihistamine Drugs Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global antihistamine drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global antihistamine drugs market.
  • Insights about market determinants that are stimulating the global antihistamine drugs market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Antihistamine Drugs Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Antihistamine Drugs Market by Type
    • 5.1.1. H-1 Receptor Antagonist
      • 5.1.1.1. Brompheniramine
      • 5.1.1.2. Diphenhydramine
      • 5.1.1.3. Cetirizine
      • 5.1.1.4. Desloratadine
      • 5.1.1.5. Loratadine
      • 5.1.1.6. Fexofenadine
      • 5.1.1.7. Others
    • 5.1.2. H-2 Receptor Antagonists
      • 5.1.2.1. Cimetidine
      • 5.1.2.2. Famotidine
      • 5.1.2.3. Nizatidine
      • 5.1.2.4. Ranitidine
      • 5.1.2.5. Other
  • 5.2. Global Antihistamine Drugs Market by Application
    • 5.2.1. Flu and Cold
    • 5.2.2. Allergy
    • 5.2.3. Dermatitis
    • 5.2.4. Urticaria
    • 5.2.5. Others
  • 5.3. Global Antihistamine Drugs Market by End-User
    • 5.3.1. Homecare
    • 5.3.2. Hospitals and Clinics
    • 5.3.3. Others (ACS)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East & Africa

7. Company Profiles

  • 7.1. Akorn, Inc.
  • 7.2. Almirall S.A.
  • 7.3. AstraZeneca PLC
  • 7.4. Bayer AG
  • 7.5. Boehringer Ingelheim International GmbH.
  • 7.6. Bristol-Myers Squibb Co.
  • 7.7. Cadila Pharmaceuticals, Ltd.
  • 7.8. F. Hoffmann-La Roche, Ltd.
  • 7.9. GlaxoSmithKline PLC
  • 7.10. Johnson & Johnson Services, Ltd.
  • 7.11. Meda Consumer Healthcare, Inc.
  • 7.12. Merck & Co.
  • 7.13. Mylan N.V.
  • 7.14. Novartis International AG
  • 7.15. Pfizer, Inc.

LIST OF TABLES

  • 1. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 4. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 6. GLOBAL BROMPHENIRAMINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL DIPHENHYDRAMINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL CETIRIZINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL DESLORATADINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL LORATADINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL FEXOFENADINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL OTHERS H-1 RECEPTOR ANTAGONISTS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL CIMETIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL FAMOTIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 15. GLOBAL NIZATIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 16. GLOBAL RANITIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 17. OTHER H-2 RECEPTOR ANTAGONISTS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 18. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 19. GLOBAL ANTIHISTAMINE DRUGS IN ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 20. GLOBAL ANTIHISTAMINE DRUGS IN FLU AND COLD MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 21. GLOBAL ANTIHISTAMINE DRUGS IN DERMATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 22. GLOBAL ANTIHISTAMINE DRUGS IN URTICARIA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 23. GLOBAL ANTIHISTAMINE DRUGS IN OTHERS APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 24. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 25. GLOBAL ANTIHISTAMINE DRUGS FOR HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 26. GLOBAL ANTIHISTAMINE DRUGS FOR HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 27. GLOBAL ANTIHISTAMINE DRUGS FOR OTHERS END-USER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 28. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 29. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 30. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 31. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 32. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 33. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 34. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 35. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 36. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 37. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 38. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 39. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 40. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 41. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 42. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 43. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 44. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 2. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 3. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 4. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 5. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 7. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 9. GLOBAL BROMPHENIRAMINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 10. GLOBAL DIPHENHYDRAMINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 11. GLOBAL CETIRIZINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 12. GLOBAL DESLORATADINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 13. GLOBAL LORATADINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 14. GLOBAL FEXOFENADINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 15. GLOBAL OTHERS H-1 RECEPTOR ANTAGONISTS DRUG MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 16. GLOBAL CIMETIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 17. GLOBAL FAMOTIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 18. GLOBAL NIZATIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 19. GLOBAL RANITIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 20. OTHER H-2 RECEPTOR ANTAGONISTS DRUG MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 21. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 22. GLOBAL ANTIHISTAMINE DRUGS IN ALLERGY MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 23. GLOBAL ANTIHISTAMINE DRUGS IN FLU AND COLD MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 24. GLOBAL ANTIHISTAMINE DRUGS IN DERMATITIS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 25. GLOBAL ANTIHISTAMINE DRUGS IN URTICARIA MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 26. GLOBAL ANTIHISTAMINE DRUGS FOR HOMECARE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 27. GLOBAL ANTIHISTAMINE DRUGS FOR HOSPITALS AND CLINICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 28. GLOBAL ANTIHISTAMINE DRUGS FOR OTHERS END-USER MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 29. US ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. UK ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. FRANCE ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 34. ITALY ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 35. SPAIN ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 36. REST OF EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 37. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 38. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 39. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 40. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 41. REST OF ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)

42. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2027($ MILLION